Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > DMTK DermTech > Key Indicators
DMTK DermTech
2.610
+0.200+8.30%
Pre Mkt Price
2.649
+0.039+1.51%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
527.58% 61.2193 1,888.94% 90.2943 316.45% 48.4055 159.08% 15.284
Receivable Turnover(T)
-41.63% 3.2935 -44.70% 3.4727 -15.89% 3.8055 -18.44% 4.4445
Inventory Turnover(T)
-56.46% 14.9433 -51.78% 13.2348 -39.29% 23.2553 -57.96% 36.1781
Fixed Assets Turnover(T)
-52.16% 0.6987 -73.98% 0.887 -70.50% 0.8319 -50.35% 1.5759
Total Asset Rate(T)
-4.11% 0.0633 7.27% 0.0575 27.03% 0.0517 -44.36% 0.0744
ROIC
-36.37% -52.510% -44.81% -45.130% -44.30% -38.667% 43.37% -52.084%
ROE
-38.61% -56.284% -52.08% -47.480% -51.12% -40.571% 42.41% -53.437%
ROA
-30.66% -49.362% -43.86% -43.046% -43.63% -37.013% 38.53% -49.253%
Efficiency Ratios
Profitability Ratios TTM
Gross Margin
-46.35% 7.679% -23.71% 9.763% 568.91% 7.029% 759.72% 10.762%
Operating Margin
-40.46% -787.290% -38.85% -754.298% -18.74% -722.652% -9.03% -653.810%
Net Margin
-36.26% -779.583% -34.11% -748.289% -13.07% -716.505% -10.48% -661.725%
EBITDA Margin
-39.99% -7.6205% -36.74% -7.3176% -17.19% -7.0265% -7.28% -6.3441%
R & D Expense Ratio
50.44% 169.820% 62.86% 167.320% 60.95% 156.140% 52.72% 137.360%
Sales Expense Ratio
46.24% 397.620% 43.39% 378.910% 24.47% 356.860% 16.19% 317.410%
Administration Expense Rate
19.71% 227.530% 15.24% 217.840% -4.09% 216.680% -10.68% 209.800%
Financial Health Ratios
Long-Term Debt to Equity Ratio
429.32% 14.239% 19,642.92% 12.557% 13,596.76% 10.560% 668.48% 2.736%
Total Assets to Common Equity
16.87% 125.212% 17.34% 121.019% 14.07% 117.712% -1.64% 108.102%
Debt to Asset Ratio
365.66% 15.344% 12,771.66% 13.580% 9,451.46% 11.452% 548.41% 3.421%
Current Ratio
-59.78% 9.4685 -65.79% 12.1862 -60.88% 14.429 55.04% 19.1137
Quick Ratio
-60.88% 9.1386 -66.33% 11.9136 -61.38% 14.1501 56.41% 18.8144
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in La Jolla, CA.
CEO: Dr. John D Dobak, M.D.
Market: NASDAQ
Listing Date: 06/20/2017
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist